Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.

News

Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Important Notice: Investments in unquoted companies carries high risks and investors could lose all funds invested. Investors should not invest if capital is required in the near term. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Past performance is not a guide to the future performance of an investment, and investors are encouraged to take independent legal, tax and financial advice before considering an investment.
Almac and Elasmogen receive £2m grant

24th August 2018

The biopharmaceutical company Almac Discovery - part of the contract development and manufacturing organisation (CDMO) Almac Group -and Elasmogen, a…

Full article
Glyconics sign hardware partner agreement

11th August 2018

  Deepbridge are pleased to report that Glyconics, which is part of the Deepbridge Life Sciences SEIS portfolio, have signed a hardware partner…

Full article
Women in Financial Advice Awards 2018

28th July 2018

      “I am delighted to report that Louise Farley, Deepbridge Partner and Head of Business Development, has been shortlisted for the 'Woman of…

Full article
Deepbridge nominated for 4 awards

2nd July 2018

  Deepbridge are delighted to announce that we have been nominated for 4 awards at the upcoming Growth Investor Awards 2018, taking place in London…

Full article
Deepbridge case studies available

17th June 2018

  We now have the following Deepbridge case studies available:   Enterprise Investment Scheme Case Studies Income Tax Capital Gains Tax EIS…

Full article
Deepbridge investee companies shortlisted for awards

1st June 2018

  Deepbridge are delighted to announce that investee companies Enso Tyres, Metix Medical, Beamline Diagnostics, Liverpool ChiroChem and Zilico have…

Full article
Touch Biometrix in new market report

10th May 2018

  Deepbridge are delighted to announce that Touch Biometrix, part of the Deepbridge Innovation SEIS portfolio, have been recognised as a key global…

Full article
Deepbridge leads on £5.4m investment in vTime

20th April 2018

Deepbridge, are delighted to announce we are leading a £5.4 million Series A funding round for vTime - a Liverpool based company, whose VR sociable…

Full article
Offsetting a tax liability in 2017/18 tax year

29th March 2018

If looking to utilise the Enterprise Investment Scheme (or Seed Enterprise Investment Scheme) to offset a tax liability in the 2017/18 tax year…

Full article
Closing dates for EIS deployment in 2017/18 tax year

20th February 2018

Deepbridge can confirm that the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS have capacity for deployment prior to 5 April 2018…

Full article
Deepbridge welcomes 3 new members

5th February 2018

As part of Deepbridge's continuing growth, we are delighted to introduce 3 new members of the team! All come with a wealth of experience in their…

Full article
How to pick the right EIS provider for your clients: Five thematic questions

31st January 2018

here has been a significant uplift in the degree of interest in Enterprise Investment Schemes (EIS) recently, particularly since the Budget and the…

Full article